Edited by: TJVNews.com

In a significant announcement for the healthcare community, Ken Langone, 88, co-founder of Home Depot and chair of NYU Langone’s board of trustees, along with Robert I. Grossman, CEO of NYU Langone Health, will retire next year, as was reported in The New York Post. Their departures mark the end of an era of transformative leadership for the renowned hospital system.

Ken Langone and Robert Grossman have been pivotal figures in the growth and success of NYU Langone Health. Grossman, who has served as CEO since 2007, reflected on their achievements in a message to staff, saying, “It is immensely gratifying to know that we have transformed NYU Langone Health into an institution that is simply nonpareil,” The Post report said. He expressed immense pride in the collective efforts of the team, attributing the institution’s success to their dedication and hard work. Grossman, who is also the dean of NYU Grossman School of Medicine, emphasized that their accomplishments were a team effort, stating, “Without you, it never would have been possible. But all good things must come to an end.”

Langone and Grossman will step down at the end of August 2025, leaving behind a legacy of innovation and expansion that has positioned NYU Langone as a leader in healthcare.

Fiona Duckenmiller, who has been co-chair of the board of trustees for the past seven years, will replace Langone as the sole chair. As per the information provided in The Post report, Duckenmiller has been a member of the board since 2006 and brings a wealth of experience and continuity to the role. Under her leadership, the board will continue to uphold the high standards and strategic vision that have characterized Langone’s tenure.

Under the leadership of Langone and Grossman, NYU Langone Health has undergone a remarkable expansion. The institution now comprises six inpatient locations, including the prestigious Perlmutter Cancer Center, and more than 300 outpatient sites across New York and Florida, as was noted in the information contained in The Post report. The system also boasts two medical schools, further cementing its reputation as a leader in medical education and healthcare. This growth has been fueled by a commitment to excellence in patient care, medical education, and research.

Since taking the helm in 2007, Grossman and Langone have also overseen a dramatic increase in NYU Langone’s revenue, growing from $2 billion to over $12 billion by 2023.

Grossman’s tenure as CEO has been marked by a focus on strategic development and innovation. His leadership has not only expanded the physical footprint of NYU Langone but also enhanced its reputation as a leading healthcare provider, as was explained in The Post report. The integration of cutting-edge technology, patient-centered care, and world-class medical research has been a hallmark of Grossman’s approach.

NYU Langone’s commitment to excellence has been recognized with numerous awards. In September 2023, the system received the Bernard A. Birnbaum, MD, Quality Leadership Award for superior patient care and the Ambulatory Quality and Accountability Award for excellence in outpatient care, as was noted in The Post report. These accolades established NYU Langone as the top-ranked healthcare system in the country, reflecting the high standards of care and patient satisfaction achieved under Grossman’s leadership.

In July 2023, the Langone family made a transformative $200 million donation to NYU Grossman Long Island School of Medicine, enabling the institution to offer tuition-free education.